Glial modulators as potential treatments of psychostimulant abuse

Advances in Pharmacology

Volumn 69, Issue , 2014, Pages 1-69

  Beardsley, Patrick M ^a   Hauser, Kurt F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Astroglia; Cocaine; Glia; Medication; Methamphetamine; Microglia

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM AGENTS; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL MODULATING AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PATTERN RECOGNITION RECEPTOR; PSYCHOSTIMULANT AGENT; SIGMA 1 OPIATE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; DRUG ABUSE; DRUG TARGETING; GLIA; HUMAN; INNATE IMMUNITY; LOCOMOTION; MACROGLIA; MICROGLIA; MOLECULAR BIOLOGY; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRESS;

ASTROGLIA; COCAINE; GLIA; MEDICATION; METHAMPHETAMINE; MICROGLIA;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; MINOCYCLINE; NEUROGLIA; PYRIDINES; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84893165924     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/B978-0-12-420118-7.00001-9     Document Type: Chapter

References (368)

1. Abdel-Salam O.M.E. Drugs used to treat Parkinson's disease, present status and future directions. CNS and Neurological Disorders Drug Targets 2008, 7(4):321-342. 10.2174/187152708786441867.
2. Abulseoud O.A., Miller J.D., Wu J., Choi D.S., Holschneider D.P. Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm. Brain Research 2012, 1456:14-21. 10.1016/j.brainres.2012.03.045.
3. Airaksinen M.S., Saarma M. The GDNF family: Signalling, biological functions and therapeutic value. Nature Reviews. Neuroscience 2002, 3(5):383-394. 10.1038/nrn812.
4. Airavaara M., Planken A., Gaddnas H., Piepponen T.P., Saarma M., Ahtee L. Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice. The European Journal of Neuroscience 2004, 20(9):2336-2344. 10.1111/j.1460-9568.2004.03700.x.
5. Akiyama K., Isao T., Ide S., Ishikawa M., Saito A. mRNA expression of the Nurr1 and NGFI-B nuclear receptor families following acute and chronic administration of methamphetamine. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008, 32(8):1957-1966. Retrieved from PM: 18930103.
6. Albertson D.N., Pruetz B., Schmidt C.J., Kuhn D.M., Kapatos G., Bannon M.J. Gene expression profile of the nucleus accumbens of human cocaine abusers: Evidence for dysregulation of myelin. Journal of Neurochemistry 2004, 88(5):1211-1219. Retrieved from PM: 15009677. 10.1046/j.1471-4159.2003.02247.x.
7. Alvarez V.M., Rama Rao K.V., Brahmbhatt M., Norenberg M.D. Interaction between cytokines and ammonia in the mitochondrial permeability transition in cultured astrocytes. Journal of Neuroscience Research 2011, 89(12):2028-2040. Retrieved from PM: 21748779. 10.1002/jnr.22708.
8. Angulo J.A., Angulo N., Yu J. Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum. Annals of the New York Academy of Sciences 2004, 1025:171-180.
9. Appel E., Kolman O., Kazimirsky G., Blumberg P.M., Brodie C. Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli. Neuroreport 1997, 8(15):3309-3312. Retrieved from PM: 9351662.
10. Araque A., Parpura V., Sanzgiri R.P., Haydon P.G. Tripartite synapses: Glia, the unacknowledged partner. Trends in Neurosciences 1999, 22(5):208-215.
11. Armbruster B.N., Li X., Pausch M.H., Herlitze S., Roth B.L. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(12):5163-5168. Retrieved from PM: 17360345.
12. Bachoo R.M., Kim R.S., Ligon K.L., Maher E.A., Brennan C., Billings N., et al. Molecular diversity of astrocytes with implications for neurological disorders. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(22):8384-8389. Retrieved from PM: 15155908.
13. Bahi A., Boyer F., Chandrasekar V., Dreyer J.L. Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference, and reinstatement in rats. Psychopharmacology 2008, 199(2):169-182. 10.1007/s00213-008-1164-1.
14. Banister S.D., Kassiou M. The therapeutic potential of sigma (sigma) receptors for the treatment of central nervous system diseases: Evaluation of the evidence. Current Pharmaceutical Design 2012, 18(7):884-901.
15. Bannon M., Kapatos G., Albertson D. Gene expression profiling in the brains of human cocaine abusers. Addiction Biology 2005, 10(1):119-126. [pii] N098X4GAP1KET58P. Retrieved from PM: 15849025. 10.1080/13556210412331308921.
16. Beardsley P.M. Preclinical evidence that chemically modulating glial and neuroinflammatory activity affects drug-maintained and relapse behavior with a focus on methamphetamine 2013.
17. Beardsley P.M., Shelton K.L., Hendrick E., Johnson K.W. The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse. European Journal of Pharmacology 2010, 637(1-3):102-108. 10.1016/j.ejphar.2010.04.010.
18. Beers D.R., Henkel J.S., Zhao W., Wang J., Appel S.H. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(40):15558-15563. [pii] 0807419105. Retrieved from PM: 18809917. 10.1073/pnas.0807419105.
19. Behensky A.A., Cortes-Salva M., Seminerio M.J., Matsumoto R.R., Antilla J.C., Cuevas J. In vitro evaluation of guanidine analogs as sigma receptor ligands for potential anti-stroke therapeutics. The Journal of Pharmacology and Experimental Therapeutics 2013, 344(1):155-166. [pii] jpet.112.199513. Retrieved from PM: 23065135. 10.1124/jpet.112.199513.
20. Beitner-Johnson D., Nestler E.J. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. Journal of Neurochemistry 1991, 57(1):344-347.
21. Ben-Ami O., Kinor N., Perelman A., Yadid G. Dopamine-1 receptor agonist, but not cocaine, modulates sigma(1) gene expression in SVG cells. Journal of Molecular Neuroscience 2006, 29(2):169-176. doi: JMN:29:2:169 [pii]. Retrieved from PM: 16954606.
22. Benz B., Grima G., Do K.Q. Glutamate-induced homocysteic acid release from astrocytes: Possible implication in glia-neuron signaling. Neuroscience 2004, 124(2):377-386. 10.1016/j.neuroscience.2003.08.067.
23. Berglind W.J., See R.E., Fuchs R.A., Ghee S.M., Whitfield T.W., Miller S.W., et al. A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. European Journal of Neuroscience 2007, 26(3):757-766. 10.1111/j.1460-9568.2007.05692.x.
24. Bernardino A.L., Kaushal D., Philipp M.T. The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi. The Journal of Infectious Diseases 2009, 199(9):1379-1388. 10.1086/597807.
25. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annual Review of Immunology 2006, 24:353-389. Retrieved from PM: 16551253. 10.1146/annurev.immunol.24.021605.090552.
26. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B.L., et al. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 1998, 391(6664):281-285. 10.1038/34651.
27. Bianchi M.E. DAMPs, PAMPs and alarmins: All we need to know about danger. Journal of Leukocyte Biology 2007, 81(1):1-5. Retrieved from PM: 17032697.
28. Biber K., Neumann H., Inoue K., Boddeke H.W. Neuronal 'On' and 'Off' signals control microglia. Trends in Neurosciences 2007, 30(11):596-602.
29. Block M.L., Hong J.S. Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochemical Society Transactions 2007, 35(Pt. 5):1127-1132. [pii] BST0351127. Retrieved from PM: 17956294. 10.1042/BST0351127.
30. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nature Reviews. Neuroscience 2007, 8(1):57-69. Retrieved from PM: 17180163.
31. Blum D., Chtarto A., Tenenbaum L., Brotchi J., Levivier M. Clinical potential of minocycline for neurodegenerative disorders. Neurobiology of Disease 2004, 17(3):359-366. 10.1016/j.nbd.2004.07.012.
32. Boger H.A., Middaugh L.D., Patrick K.S., Ramamoorthy S., Denehy E.D., Zhu H., et al. Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice. The Journal of Neuroscience 2007, 27(33):8816-8825. Retrieved from PM: 17699663.
33. Boileau I., Rusjan P., Houle S., Wilkins D., Tong J., Selby P., et al. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?. The Journal of Neuroscience 2008, 28(39):9850-9856. [pii] 28/39/9850. Retrieved from PM: 18815269. 10.1523/JNEUROSCI.3008-08.2008.
34. Bolanos C.A., Nestler E.J. Neurotrophic mechanisms in drug addiction. Neuromolecular Medicine 2004, 5(1):69-83. 10.1385/nmm:5:1:069.
35. Bowers M.S., Chen B.T., Bonci A. AMPA receptor synaptic plasticity induced by psychostimulants: The past, present, and therapeutic future. Neuron 2010, 67(1):11-24. Retrieved from PM: 20624588.
36. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Medicine 1996, 2(7):788-794.
37. Bruns A.M., Pollpeter D., Hadizadeh N., Myong S., Marko J.F., Horvath C.M. ATP hydrolysis enhances RNA recognition and antiviral signal transduction by the innate immune sensor, laboratory of genetics and physiology 2 (LGP2). The Journal of Biological Chemistry 2013, 288(2):938-946.
38. Buller K.M., Carty M.L., Reinebrant H.E., Wixey J.A. Minocycline: A neuroprotective agent for hypoxic-ischemic brain injury in the neonate?. Journal of Neuroscience Research 2009, 87(3):599-608. 10.1002/jnr.21890.
39. Büttner A. The neuropathology of drug abuse. Neuropathology and Applied Neurobiology 2011, 37(2):118-134. Retrieved from PM: 20946118.
40. Cadet J.L., Jayanthi S. Epigenetics of methamphetamine-induced changes in glutamate function. Neuropsychopharmacology 2013, 38(1):248-249. Retrieved from PM: 23147489.
41. Cadet J.L., Krasnova I.N. Molecular bases of methamphetamine-induced neurodegeneration. International Review of Neurobiology 2009, 88:101-119. [pii] S0074-7742(09)88005-7. Retrieved from PM: 19897076. 10.1016/S0074-7742(09)88005-7.
42. Cadet J.L., Krasnova I.N., Jayanthi S., Lyles J. Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms. Neurotoxicity Research 2007, 11(3-4):183-202. Retrieved from PM: 17449459.
43. Camacho A., Massieu L. Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Archives of Medical Research 2006, 37(1):11-18. 10.1016/j.arcmed.2005.05.014.
44. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nature Neuroscience 2006, 9(7):917-924. Retrieved from PM: 16732273.
45. Carnicella S., Ron D. GDNF-A potential target to treat addiction. Pharmacology & Therapeutics 2009, 122(1):9-18. [pii] S0163-7258(08)00235-0. Retrieved from PM: 19136027. 10.1016/j.pharmthera.2008.12.001.
46. Cass W.A. GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine. The Journal of Neuroscience 1996, 16(24):8132-8139. Retrieved from PM: 8987838.
47. Cen X.B., Nitta A., Ohya S., Zhao Y.L., Ozawa N., Mouri A., et al. An analog of a dipeptide-like structure of FK506 increases glial cell line-derived neurotrophic factor expression through cAMP response element-binding protein activated by heat shock protein 90/Akt signaling pathway. Journal of Neuroscience 2006, 26(12):3335-3344. 10.1523/jneurosci.5010-05.2006.
48. Cen P., Ye L., Su Q.J., Wang X., Li J.L., Lin X.Q., et al. Methamphetamine inhibits Toll-like receptor 9-mediated anti-HIV activity in macrophages. AIDS Research and Human Retroviruses 2013, 29(8):1129-1137. Retrieved from PM: 23751096. 10.1089/AID.2012.0264.
49. Chan H., Hazell A.S., Desjardins P., Butterworth R.F. Effects of ammonia on glutamate transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes. Neurochemistry International 2000, 37(2-3):243-248. [pii] S0197-0186(00)00026-7. Retrieved from PM: 10812209.
50. Chao C.C., Hu S., Peterson P.K. Glia: The not so innocent bystanders. Journal of Neurovirology 1996, 2(4):234-239. Retrieved from PM: 8799214.
51. Chao C.C., Hu S., Sheng W.S., Bu D., Bukrinsky M.I., Peterson P.K. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 1996, 16(3):276-284. Retrieved from PM: 8833198. 10.1002/(SICI)1098-1136(199603)16:3<276::AID-GLIA10>3.0.CO;2-X.
52. Chen X.H., Ma X.M., Jiang Y., Pi R.B., Liu Y.Y., Ma L.L. The prospects of minocycline in multiple sclerosis. Journal of Neuroimmunology 2011, 235(1-2):1-8. 10.1016/j.jneuroim.2011.04.006.
53. Chen P.S., Peng G.S., Li G., Yang S., Wu X., Wang C.C., et al. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Molecular Psychiatry 2006, 11(12):1116-1125. 10.1038/sj.mp.4001893.
54. Cho Y., Crichlow G.V., Vermeire J.J., Leng L., Du X., Hodsdon M.E., et al. Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(25):11313-11318. 10.1073/pnas.1002716107.
55. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1:623-634.
56. Choi D.W. Excitotoxic cell death. Journal of Neurobiology 1992, 23(9):1261-1276.
57. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. The Journal of Biological Chemistry 1999, 274(16):10689-10692.
58. Clark K.H., Wiley C.A., Bradberry C.W. Psychostimulant abuse and neuroinflammation: Emerging evidence of their interconnection. Neurotoxicity Research 2013, 23(2):174-188. Retrieved from PM: 22714667. 10.1007/s12640-012-9334-7.
59. Coghlan M.P., Culbert A.A., Cross D.A., Corcoran S.L., Yates J.W., Pearce N.J., et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chemistry & Biology 2000, 7(10):793-803. Retrieved from PM: 11033082.
60. Coller J.K., Hutchinson M.R. Implications of central immune signaling caused by drugs of abuse: Mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Pharmacology & Therapeutics 2012, 134(2):219-245.
61. Colton C.A. Heterogeneity of microglial activation in the innate immune response in the brain. Journal of Neuroimmune Pharmacology 2009, 4(4):399-418. Retrieved from PM: 19655259.
62. Conklin B.R., Hsiao E.C., Claeysen S., Dumuis A., Srinivasan S., Forsayeth J.R., et al. Engineering GPCR signaling pathways with RASSLs. Nature Methods 2008, 5(8):673-678. Retrieved from PM: 18668035.
63. Cooper Z.D., Jones J.D., Comer S.D. Glial modulators: A novel pharmacological approach to altering the behavioral effects of abused substances. Expert Opinion on Investigational Drugs 2012, 21(2):169-178. 10.1517/13543784.2012.651123.
64. Costa A., Gupta R., Signorino G., Malara A., Cardile F., Biondo C., et al. Activation of the NLRP3 inflammasome by group B streptococci. Journal of Immunology 2012, 188(4):1953-1960.
65. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438(7070):1017-1021. 10.1038/nature04223.
66. Coward P., Wada H.G., Falk M.S., Chan S.D., Meng F., Akil H., et al. Controlling signaling with a specifically designed Gi-coupled receptor. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(1):352-357.
67. Crews F.T., Zou J., Qin L. Induction of innate immune genes in brain create the neurobiology of addiction. Brain, Behavior, and Immunity 2011, 25(Suppl. 1):S4-S12. 10.1016/j.bbi.2011.03.003.
68. Cross D.A., Culbert A.A., Chalmers K.A., Facci L., Skaper S.D., Reith A.D. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. Journal of Neurochemistry 2001, 77(1):94-102. Retrieved from PM: 11279265.
69. Cuevas J., Rodriguez A., Behensky A., Katnik C. Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors. The Journal of Pharmacology and Experimental Therapeutics 2011, 339(1):161-172. [pii] jpet.111.182816. Retrieved from PM: 21715561. 10.1124/jpet.111.182816.
70. Cui Y., Liao X.X., Liu W., Guo R.X., Wu Z.Z., Zhao C.M., et al. A novel role of minocycline: Attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain, Behavior, and Immunity 2008, 22(1):114-123. 10.1016/j.bbi.2007.07.014.
71. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nature Neuroscience 2005, 8(6):752-758.
72. Davidson C., Chen Q., Zhang X., Xiong X., Lazarus C., Lee T.H., et al. Deprenyl treatment attenuates long-term pre- and post-synaptic changes evoked by chronic methamphetamine. European Journal of Pharmacology 2007, 573(1-3):100-110. Retrieved from PM: 17651730.
73. Davidson C., Gow A.J., Lee T.H., Ellinwood E.H. Methamphetamine neurotoxicity: Necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Research. Brain Research Reviews 2001, 36(1):1-22.
74. De Leo J.A., Tawfik V.L., Lacroix-Fralish M.L. The tetrapartite synapse: Path to CNS sensitization and chronic pain. Pain 2006, 122(1-2):17-21.
75. Desagher S., Glowinski J., Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. The Journal of Neuroscience 1996, 16(8):2553-2562. Retrieved from PM: 8786431.
76. Deschepper C.F. Peptide receptors on astrocytes. Frontiers in Neuroendocrinology 1998, 19(1):20-46. 10.1006/frne.1997.0161.
77. de Wit H., Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 1981, 75(2):134-143.
78. Dews P.B. Studies on behavior. I. Differential sensitivity to pentobarbital of pecking performance in pigeons depending on the schedule of reward. The Journal of Pharmacology and Experimental Therapeutics 1955, 113(4):393-401.
79. Dickerson T.J., Yamamoto N., Ruiz D.I., Janda K.D. Immunological consequences of methamphetamine protein glycation. Journal of the American Chemical Society 2004, 126(37):11446-11447. Retrieved from PM: 15366884. 10.1021/ja047690h.
80. Dong S., Rogan S.C., Roth B.L. Directed molecular evolution of DREADDs: A generic approach to creating next-generation RASSLs. Nature Protocols 2010, 5(3):561-573. Retrieved from PM: 20203671.
81. Durand D., Carniglia L., Caruso C., Lasaga M. mGlu3 receptor and astrocytes: Partners in neuroprotection. Neuropharmacology 2013, 66:1-11. 10.1016/j.neuropharm.2012.04.009.
82. Egea-Guerrero J.J., Revuelto-Rey J., Murillo-Cabezas F., Munoz-Sanchez M.A., Vilches-Arenas A., Sanchez-Linares P., et al. Accuracy of the S100beta protein as a marker of brain damage in traumatic brain injury. Brain Injury 2012, 26(1):76-82.
83. Eketjall S., Fainzilber M., Murray-Rust J., Ibanez C.F. Distinct structural elements in GDNF mediate binding to GFRalpha1 and activation of the GFRalpha1-c-Ret receptor complex. The EMBO Journal 1999, 18(21):5901-5910. Retrieved from PM: 10545102. 10.1093/emboj/18.21.5901.
84. i, NF-κB trafficking and transcription. PLoS One 2008, 3(12):e4093.
85. El-Hage N., Podhaizer E.M., Sturgill J., Hauser K.F. Toll-like receptor expression and activation in astroglia: Differential regulation by HIV-1 Tat, gp120, and morphine. Immunological Investigations 2011, 40(5):498-522. Retrieved from PM: 21425908.
86. Equils O., Schito M.L., Karahashi H., Madak Z., Yarali A., Michelsen K.S., et al. Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: Implications of simultaneous activation of TLRs on HIV replication. Journal of Immunology 2003, 170(10):5159-5164.
87. Eyerman D.J., Yamamoto B.K. A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. Journal of Neurochemistry 2007, 103(3):1219-1227. Retrieved from PM: 17683483.
88. Facchinetti F., Del G.E., Furegato S., Passarotto M., Arcidiacono D., Leon A. Dopamine inhibits responses of astroglia-enriched cultures to lipopolysaccharide via a β-adrenoreceptor-mediated mechanism. Journal of Neuroimmunology 2004, 150(1-2):29-36. Retrieved from PM: 15081246.
89. Fan X., Luo G., Ming M., Pu P., Li L., Yang D., et al. Nurr1 expression and its modulation in microglia. Neuroimmunomodulation 2009, 16(3):162-170. Retrieved from PM: 19246938.
90. Farber K., Pannasch U., Kettenmann H. Dopamine and noradrenaline control distinct functions in rodent microglial cells. Molecular and Cellular Neurosciences 2005, 29(1):128-138.
91. Feng Y. Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction. Neurochemical Research 2008, 33(10):1940-1949.
92. Ferrari D., Chiozzi P., Falzoni S., Hanau S., Di V.F. Purinergic modulation of interleukin-1 β release from microglial cells stimulated with bacterial endotoxin. The Journal of Experimental Medicine 1997, 185(3):579-582.
93. Fiacco T.A., Agulhon C., McCarthy K.D. Sorting out astrocyte physiology from pharmacology. Annual Review of Pharmacology and Toxicology 2009, 49:151-174. Retrieved from PM: 18834310.
94. Figiel I. Pro-inflammatory cytokine TNF-α as a neuroprotective agent in the brain. Acta Neurobiologiae Experimentalis (Wars) 2008, 68(4):526-534. Retrieved from PM: 19112477. http://www.crossref.org/guestquery/.
95. Fitzgerald L.W., Ortiz J., Hamedani A.G., Nestler E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: Common adaptations among cross-sensitizing agents. The Journal of Neuroscience 1996, 16(1):274-282.
96. Fleckenstein A.E., Metzger R.R., Wilkins D.G., Gibb J.W., Hanson G.R. Rapid and reversible effects of methamphetamine on dopamine transporters. The Journal of Pharmacology and Experimental Therapeutics 1997, 282(2):834-838. Retrieved from PM: 9262348.
97. Food and Drug Administration (2007). Retrieved from http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4306b1-00-index.htm.
98. Frank M.G., Watkins L.R., Maier S.F. Stress- and glucocorticoid-induced priming of neuroinflammatory responses: Potential mechanisms of stress-induced vulnerability to drugs of abuse. Brain, Behavior, and Immunity 2011, 25(Suppl. 1):S21-S28. [pii] S0889-1591(11)00010-9. Retrieved from PM: 21256955. 10.1016/j.bbi.2011.01.005.
99. Fritz M., Klement S., El Rawas R., Saria A., Zernig G. Sigma1 receptor antagonist BD1047 enhances reversal of conditioned place preference from cocaine to social interaction. Pharmacology 2011, 87(1-2):45-48. [pii] 000322534. Retrieved from PM: 21196793. 10.1159/000322534.
100. Fuhrmann M., Bittner T., Jung C.K., Burgold S., Page R.M., Mitteregger G., et al. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nature Neuroscience 2010, 13(4):411-413.
101. Fujita Y., Kunitachi S., Iyo M., Hashimoto K. The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice. Pharmacology, Biochemistry, and Behavior 2012, 101(2):303-306. 10.1016/j.pbb.2012.01.005.
102. Fumagalli M., Brambilla R., D'Ambrosi N., Volonte C., Matteoli M., Verderio C., et al. Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors. Glia 2003, 43(3):218-230. 10.1002/glia.10248.
103. Fumagalli F., Gainetdinov R.R., Wang Y.M., Valenzano K.J., Miller G.W., Caron M.G. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. The Journal of Neuroscience 1999, 19(7):2424-2431. Retrieved from PM: 10087057.
104. Gao H.M., Hong J.S. Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression. Trends in Immunology 2008, 29(8):357-365. Retrieved from PM: 18599350.
105. Garrido-Mesa N., Zarzuelo A., Galvez J. Minocycline: Far beyond an antibiotic. British Journal of Pharmacology 2013, 169(2):337-352. 10.1111/bph.12139.
106. Garwood C.J., Pooler A.M., Atherton J., Hanger D.P., Noble W. Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death & Disease 2011, 2:e167. [pii] cddis201150. Retrieved from PM: 21633390. 10.1038/cddis.2011.50.
107. Geijtenbeek T.B., Gringhuis S.I. Signalling through C-type lectin receptors: Shaping immune responses. Nature Reviews. Immunology 2009, 9(7):465-479. [pii] nri2569. Retrieved from PM: 19521399. 10.1038/nri2569.
108. Gekker G., Hu S., Sheng W.S., Rock R.B., Lokensgard J.R., Peterson P.K. Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-β1. International Immunopharmacology 2006, 6(6):1029-1033. [pii] S1567-5769(05)00354-1. Retrieved from PM: 16644490. 10.1016/j.intimp.2005.12.005.
109. George O., Mandyam C.D., Wee S., Koob G.F. Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology. 2008, 33(10):2474-2482.
110. Ghitza U.E., Zhai H.F., Wu P., Airavaara M., Shaham Y., Lu L. Role of BDNF and GDNF in drug reward and relapse: A review. Neuroscience and Biobehavioral Reviews 2010, 35(2):157-171. 10.1016/j.neubiorev.2009.11.009.
111. Gibson L.C., Hastings S.F., McPhee I., Clayton R.A., Darroch C.E., Mackenzie A., et al. The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family. European Journal of Pharmacology 2006, 538(1-3):39-42. 10.1016/j.ejphar.2006.02.053.
112. Glowinski J., Marin P., Tence M., Stella N., Giaume C., Premont J. Glial receptors and their intervention in astrocyto-astrocytic and astrocyto-neuronal interactions. Glia 1994, 11(2):201-208. Retrieved from PM: 7927648. 10.1002/glia.440110214.
113. Gombault A., Baron L., Couillin I. ATP release and purinergic signaling in NLRP3 inflammasome activation. Frontiers in Immunology 2012, 3:414. 10.3389/fimmu.2012.00414.
114. Graham D.L., Edwards S., Bachtell R.K., DiLeone R.J., Rios M., Self D.W. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nature Neuroscience 2007, 10(8):1029-1037. [pii] nn1929. Retrieved from PM: 17618281. 10.1038/nn1929.
115. Graham D.L., Krishnan V., Larson E.B., Graham A., Edwards S., Bachtell R.K., et al. Tropomyosin-related kinase B in the mesolimbic dopamine system: Region-specific effects on cocaine reward. Biological Psychiatry 2009, 65(8):696-701. 10.1016/j.biopsych.2008.09.032.
116. Gramage E., Herradon G. Connecting Parkinson's disease and drug addiction: Common players reveal unexpected disease connections and novel therapeutic approaches. Current Pharmaceutical Design 2011, 17(5):449-461. [pii] BSP/CPD/E-Pub/000336. Retrieved from PM: 21375485.
117. Green-Sadan T., Kinor N., Roth-Deri I., Geffen-Aricha R., Schindler C.J., Yadid G. Transplantation of glial cell line-derived neurotrophic factor-expressing cells into the striatum and nucleus accumbens attenuates acquisition of cocaine self-administration in rats. European Journal of Neuroscience 2003, 18(7):2093-2098. 10.1046/j.1460-9568.2003.02943.x.
118. Gregory E.N., Delaney A., AbdelMoaty S., Bas D.B., Codeluppi S., Wigerblad G., et al. Pentoxifylline and propentofylline prevent proliferation and activation of the mammalian target of rapamycin and mitogen activated protein kinase in cultured spinal astrocytes. Journal of Neuroscience Research 2013, 91(2):300-312. 10.1002/jnr.23144.
119. Grimm J.W., Hope B.T., Wise R.A., Shaham Y. Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 2001, 412(6843):141-142.
120. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: Implications for incubation of cocaine craving. The Journal of Neuroscience 2003, 23(3):742-747.
121. Guillot T.S., Richardson J.R., Wang M.Z., Li Y.J., Taylor T.N., Ciliax B.J., et al. PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides 2008, 42(4):423-434. [pii] S0143-4179(08)00051-6. Retrieved from PM: 18533255. 10.1016/j.npep.2008.04.003.
122. Guo G., Bhat N.R. Hypoxia/reoxygenation differentially modulates NF-κB activation and iNOS expression in astrocytes and microglia. Antioxidants & Redox Signaling 2006, 8(5-6):911-918. Retrieved from PM: 16771681. 10.1089/ars.2006.8.911.
123. Hagino Y., Kariura Y., Manago Y., Amano T., Wang B., Sekiguchi M., et al. Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia. Glia 2004, 47(1):68-77.
124. Hall A., Cruz Y., Katnik C., Cuevas J., Pennypacker K. Sigma receptor agonists suppress the activation of microglia and the subsequent release of cytotoxins. Experimental Neurology 2006, 198(2):570-571. 10.1016/j.expneurol.2006.02.047.
125. Hall F.S., Drgonova J., Goeb M., Uhl G.R. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 2003, 28(8):1485-1490. 10.1038/sj.npp.1300192.
126. Hall A.A., Herrera Y., Ajmo C.T., Cuevas J., Pennypacker K.R. Sigma receptors suppress multiple aspects of microglial activation. Glia 2009, 57(7):744-754. 10.1002/glia.20802.
127. Halliwell B. Reactive oxygen species and the central nervous system. Journal of Neurochemistry 1992, 59:1609-1623.
128. Halpin L.E., Yamamoto B.K. Peripheral ammonia as a mediator of methamphetamine neurotoxicity. The Journal of Neuroscience 2012, 32(38):13155-13163. [pii] 32/38/13155. Retrieved from PM: 22993432. 10.1523/JNEUROSCI.2530-12.2012.
129. Hardingham G.E., Fukunaga Y., Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nature Neuroscience 2002, 5(5):405-414. [pii] nn835. Retrieved from PM: 11953750. 10.1038/nn835.
130. Hashimoto K., Ishima T. A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: Translation initiation [corrected] factor eIF4AI. PLoS One 2010, 5(11):e15430. 10.1371/journal.pone.0015430.
131. Hauser K.F., Fitting S., Dever S.M., Podhaizer E.M., Knapp P.E. Opiate drug use and the pathophysiology of neuroAIDS. Current HIV Research 2012, 10(5):435-452. Retrieved from PM: 22591368.
132. Hayashi T., Justinova Z., Hayashi E., Cormaci G., Mori T., Tsai S.Y., et al. Regulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats. The Journal of Pharmacology and Experimental Therapeutics 2010, 332(3):1054-1063.
133. 2+ signaling and cell survival. Cell 2007, 131(3):596-610. [pii] S0092-8674(07)01099-9. Retrieved from PM: 17981125. 10.1016/j.cell.2007.08.036.
134. Haydon P.G., Blendy J., Moss S.J., Jackson F.R. Astrocytic control of synaptic transmission and plasticity: A target for drugs of abuse?. Neuropharmacology 2009, 56:83-90. 10.1016/j.neuropharm.2008.06.050.
135. Haydon P.G., Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiological Reviews 2006, 86(3):1009-1031. Retrieved from PM: 16816144.
136. Haynes S.E., Hollopeter G., Yang G., Kurpius D., Dailey M.E., Gan W.B., et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nature Neuroscience 2006, 9(12):1512-1519.
137. Heinzerling K. Brief introduction to current research on glial/neuro-inflammatory processes and drug abuse and summary/discussion of highlights from symposium presentations 2013.
138. Hemby S.E. Morphine-induced alterations in gene expression of calbindin immunopositive neurons in nucleus accumbens shell and core. Neuroscience 2004, 126(3):689-703.
139. + currents and nicotinic receptors in astrocytes of the hippocampal CA1 region. Neuropharmacology 2009, 56(6-7):975-983. 10.1016/j.neuropharm.2009.01.024.
140. Hertz L. Functional interactions between neurons and astrocytes I. Turnover and metabolism of putative amino acid transmitters. Progress in Neurobiology 1979, 13(3):277-323. [pii] 0301-0082(79)90018-2. Retrieved from PM: 42117.
141. Hertz L., Chen Y., Gibbs M.E., Zang P., Peng L. Astrocytic adrenoceptors: A major drug target in neurological and psychiatric disorders?. Current Drug Targets. CNS and Neurological Disorders 2004, 3(3):239-267.
142. Hertz L., Zielke H.R. Astrocytic control of glutamatergic activity: Astrocytes as stars of the show. Trends in Neurosciences 2004, 27(12):735-743.
143. Horger B.A., Iyasere C.A., Berhow M.T., Messer C.J., Nestler E.J., Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. The Journal of Neuroscience 1999, 19(10):4110-4122.
144. Horvath R.J., Deleo J.A. Morphine enhances microglial migration through modulation of P2X4 receptor signaling. Journal of Neuroscience 2009, 29(4):998-1005. Retrieved from PM: 19176808.
145. Horvath R.J., Romero-Sandoval E.A., De Leo J.A. Inhibition of microglial P2X4 receptors attenuates morphine tolerance, Iba1, GFAP and μ opioid receptor protein expression while enhancing perivascular microglial ED2. Pain 2010, 150(3):401-413. Retrieved from PM: 20573450.
146. Hosli E., Hosli L. Receptors for neurotransmitters on astrocytes in the mammalian central-nervous-system. Progress in Neurobiology 1993, 40(4):477-506. 10.1016/0301-0082(93)90019-o.
147. Hosli L., Hosli E., Maelicke A., Schroder H. Peptidergic and cholinergic receptors on cultured astrocytes of different regions of the rat CNS. Progress in Brain Research 1992, 94:317-329.
148. Howlett A.C., Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., Porrino L.J. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004, 47:345-358. 10.1016/j.neuropharm.2004.07.030.
149. Hu X., Zhang D., Pang H., Caudle W.M., Li Y., Gao H., et al. Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Journal of Immunology 2008, 181(10):7194-7204. [pii] 181/10/7194. Retrieved from PM: 18981141.
150. Huang Y.N., Wu C.H., Lin T.C., Wang J.Y. Methamphetamine induces heme oxygenase-1 expression in cortical neurons and glia to prevent its toxicity. Toxicology and Applied Pharmacology 2009, 240(3):315-326.
151. Hutchinson M.R., Lewis S.S., Coats B.D., Skyba D.A., Crysdale N.Y., Berkelhammer D.L., et al. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain, Behavior, and Immunity 2009, 23(2):240-250. 10.1016/j.bbi.2008.09.012.
152. Hutchinson M.R., Shavit Y., Grace P.M., Rice K.C., Maier S.F., Watkins L.R. Exploring the neuroimmunopharmacology of opioids: An integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacological Reviews 2011, 63(3):772-810.
153. Hyman S.E. Addiction: A disease of learning and memory. The American Journal of Psychiatry 2005, 162(8):1414-1422.
154. Imam S.Z., Jankovic J., Ali S.F., Skinner J.T., Xie W., Conneely O.M., et al. Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice. The FASEB Journal 2005, 19(11):1441-1450. Retrieved from PM: 16126911.
155. Ivanov A., Pellegrino C., Rama S., Dumalska I., Salyha Y., Ben-Ari Y., et al. Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons. The Journal of Physiology 2006, 572(Pt. 3):789-798.
156. Iyo M., Bi Y., Hashimoto K., Inada T., Fukui S. Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram. European Journal of Pharmacology 1996, 312(2):163-170. [pii] 0014-2999(96)00479-7.
157. Iyo M., Bi Y., Hashimoto K., Tomitaka S., Inada T., Fukui S. Does an increase of cyclic AMP prevent methamphetamine-induced behavioral sensitization in rats?. Annals of the New York Academy of Sciences 1996, 801:377-383.
158. Jensen C.J., Massie A., De Keyser J. Immune players in the CNS: The astrocyte. Journal of Neuroimmune Pharmacology 2013, 8(4):824-839. Retrieved from PM: 23821340. 10.1007/s11481-013-9480-6.
159. Jiang G., Sun D., Kaplan H.J., Shao H. Retinal astrocytes pretreated with NOD2 and TLR2 ligands activate uveitogenic T cells. PLoS One 2012, 7(7):e40510.
160. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 1996, 85(7):1113-1124. [pii] S0092-8674(00)81311-2. Retrieved from PM: 8674117.
161. Jones R.S., Minogue A.M., Connor T.J., Lynch M.A. Amyloid-β-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE. Journal of Neuroimmune Pharmacology 2013, 8(1):301-311.
162. Kabe Y., Ando K., Hirao S., Yoshida M., Handa H. Redox regulation of NF-κB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antioxidants & Redox Signaling 2005, 7(3-4):395-403. Retrieved from PM: 15706086. 10.1089/ars.2005.7.395.
163. Kalivas P.W. The glutamate homeostasis hypothesis of addiction. Nature Reviews. Neuroscience 2009, 10(8):561-572.
164. Kalivas P.W., Volkow N.D. New medications for drug addiction hiding in glutamatergic neuroplasticity. Molecular Psychiatry 2011, 16(10):974-986.
165. Kang J., Jiang L., Goldman S.A., Nedergaard M. Astrocyte-mediated potentiation of inhibitory synaptic transmission. Nature Neuroscience 1998, 1(8):683-692. 10.1038/3684.
166. Kanneganti T.D., Lamkanfi M., Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007, 27(4):549-559.
167. Karin M., Cao Y., Greten F.R., Li Z.W. NF-κB in cancer: From innocent bystander to major culprit. Nature Reviews. Cancer 2002, 2(4):301-310. Retrieved from PM: 12001991. 10.1038/nrc780.
168. Katoh-Semba R., Tsuzuki M., Miyazaki N., Yoshida A., Nakajima H., Nakagawa C., et al. Distribution and immunohistochemical localization of GDNF protein in selected neural and non-neural tissues of rats during development and changes in unilateral 6-hydroxydopamine lesions. Neuroscience Research 2007, 59(3):277-287. 10.1016/j.neures.2007.07.007.
169. Katz J.L., Su T.P., Hiranita T., Hayashi T., Tanda G., Kopajtic T., et al. A role for sigma receptors in stimulant self administration and addiction. Pharmaceuticals (Basel) 2011, 4(6):880-914. Retrieved from PM: 21904468. 10.3390/ph4060880.
170. Kaushal N., Elliott M., Robson M.J., Iyer A.K., Rojanasakul Y., Coop A., et al. AC927, a sigma receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells. Molecular Pharmacology 2012, 81(3):299-308.
171. Kaushal N., Matsumoto R.R. Role of sigma receptors in methamphetamine-induced neurotoxicity. Current Neuropharmacology 2011, 9(1):54-57.
172. Kaushal N., Seminerio M.J., Robson M.J., McCurdy C.R., Matsumoto R.R. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo. European Neuropsychopharmacology 2012, 23(8):960-971.
173. Kawai T., Akira S. Signaling to NF-κB by Toll-like receptors. Trends in Molecular Medicine 2007, 13(11):460-469.
174. Kawanokuchi J., Mizuno T., Kato H., Mitsuma N., Suzumura A. Effects of interferon-β on microglial functions as inflammatory and antigen presenting cells in the central nervous system. Neuropharmacology 2004, 46(5):734-742. 10.1016/j.neuropharm.2003.11.007.
175. Keirstead H.S., Levine J.M., Blakemore W.F. Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia. 1998, 22(2):161-170.
176. Keller A.F., Beggs S., Salter M.W., De Koninck Y. Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain. Molecular Pain 2007, 3:27. 10.1186/1744-8069-3-27.
177. Khan Z.U., Koulen P., Rubinstein M., Grandy D.K., Goldman-Rakic P.S. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(4):1964-1969. 10.1073/pnas.98.4.1964.
178. Kim M.J., Dunah A.W., Wang Y.T., Sheng M. Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 2005, 46(5):745-760.
179. Kim H.S., Suh Y.H. Minocycline and neurodegenerative diseases. Behavioural Brain Research 2009, 196(2):168-179. 10.1016/j.bbr.2008.09.040.
180. Kimelberg H.K. Receptors on astrocytes-What possible functions. Neurochemistry International 1995, 26(1):27-40. 10.1016/0197-0186(94)00118-e.
181. Kishi Y., Ohta S., Kasuya N., Sakita S., Ashikaga T., Isobe M. Ibudilast: A non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall. Cardiovascular Drug Reviews 2001, 19(3):215-225.
182. Kita T., Miyazaki I., Asanuma M., Takeshima M., Wagner G.C. Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. International Review of Neurobiology 2009, 88:43-64. [pii] S0074-7742(09)88003-3. Retrieved from PM: 19897074. 10.1016/S0074-7742(09)88003-3.
183. Kitamura O., Takeichi T., Wang E.L., Tokunaga I., Ishigami A., Kubo S. Microglial and astrocytic changes in the striatum of methamphetamine abusers. Legal Medicine (Tokyo) 2010, 12(2):57-62. [pii] S1344-6223(09)00360-5. Retrieved from PM: 20110187. 10.1016/j.legalmed.2009.11.001.
184. Kofman O., Klein E., Newman M., Hamburger R., Kimchi O., Nir T., et al. Inhibition by antibiotic tetracyclines of rat cortical noradrenergic adenylate cyclase and amphetamine-induced hyperactivity. Pharmacology, Biochemistry, and Behavior 1990, 37(3):417-424.
185. Kofman O., van Embden S., Alpert C., Fuchs I. Central and peripheral minocycline suppresses motor activity in rats. Pharmacology, Biochemistry, and Behavior 1993, 44(2):397-402.
186. Kosenko E., Llansola M., Montoliu C., Monfort P., Rodrigo R., Hernandez-Viadel M., et al. Glutamine synthetase activity and glutamine content in brain: Modulation by NMDA receptors and nitric oxide. Neurochemistry International 2003, 43(4-5):493-499. [pii]. Retrieved from PM: 12742096. 10.1016/S0197-0186(03)00039-1.
187. Kourrich S., Hayashi T., Chuang J.Y., Tsai S.Y., Su T.P., Bonci A. Dynamic interaction between sigma-1 receptor and Kv12 shapes neuronal and behavioral responses to cocaine. Cell 2013, 152(1-2):236-247. [pii] S0092-8674(12)01491-2. Retrieved from PM: 23332758. 10.1016/j.cell.2012.12.004.
188. Kovalevich J., Corley G., Yen W., Rawls S.M., Langford D. Cocaine-induced loss of white matter proteins in the adult mouse nucleus accumbens is attenuated by administration of a β-lactam antibiotic during cocaine withdrawal. The American Journal of Pathology 2012, 181(6):1921-1927.
189. Krasnova I.N., Cadet J.L. Methamphetamine toxicity and messengers of death. Brain Research Reviews 2009, 60(2):379-407. [pii] S0165-0173(09)00034-4. Retrieved from PM: 19328213. 10.1016/j.brainresrev.2009.03.002.
190. Krisch B., Mentlein R. Neuropeptide receptors and astrocytes. International Review of Cytology. A Survey of Cell Biology 1994, 148(148):119-169.
191. Kristiansen L.V., Bannon M.J., Meador-Woodruff J.H. Expression of transcripts for myelin related genes in postmortem brain from cocaine abusers. Neurochemical Research 2009, 34(1):46-54.
192. Kuhn D.M., Francescutti-Verbeem D.M., Thomas D.M. Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity. Annals of the New York Academy of Sciences 2008, 1139:118-126. Retrieved from PM: 18991856.
193. B receptors to modulate interleukin release. Molecular and Cellular Neurosciences 2004, 25(2):312-322. [pii] S104474310300352X. Retrieved from PM: 15019947. 10.1016/j.mcn.2003.10.023.
194. Kumari M.V., Hiramatsu M., Ebadi M. Free radical scavenging actions of metallothionein isoforms I and II. Free Radical Research 1998, 29(2):93-101. Retrieved from PM: 9790511.
195. Larsen K.E., Fon E.A., Hastings T.G., Edwards R.H., Sulzer D. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. The Journal of Neuroscience 2002, 22(20):8951-8960. Retrieved from PM: 12388602.
196. LaVoie M.J., Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine. The Journal of Neuroscience 1999, 19(4):1484-1491. Retrieved from PM: 9952424.
197. LaVoie M.J., Hastings T.G. Peroxynitrite- and nitrite-induced oxidation of dopamine: Implications for nitric oxide in dopaminergic cell loss. Journal of Neurochemistry 1999, 73(6):2546-2554. Retrieved from PM: 10582617.
198. Ledeboer A., Liu T., Shumilla J.A., Mahoney J.H., Vijay S., Gross M.I., et al. The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain. Neuron Glia Biology 2006, 2(4):279-291. 10.1017/S1740925X0700035X.
199. Lee S., Varvel N.H., Konerth M.E., Xu G., Cardona A.E., Ransohoff R.M., et al. CX3CR1 deficiency alters microglial activation and reduces β-amyloid deposition in two Alzheimer's disease mouse models. The American Journal of Pathology 2010, 177(5):2549-2562.
200. Levesque S., Wilson B., Gregoria V., Thorpe L.B., Dallas S., Polikov V.S., et al. Reactive microgliosis: Extracellular μ-calpain and microglia-mediated dopaminergic neurotoxicity. Brain 2010, 133(Pt. 3):808-821. [pii] awp333. Retrieved from PM: 20123724. 10.1093/brain/awp333.
201. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260(5111):1130-1132.
202. Little K.Y., Krolewski D.M., Zhang L., Cassin B.J. Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users. The American Journal of Psychiatry 2003, 160(1):47-55.
203. Little K.Y., Ramssen E., Welchko R., Volberg V., Roland C.J., Cassin B. Decreased brain dopamine cell numbers in human cocaine users. Psychiatry Research 2009, 168(3):173-180. [pii] S0165-1781(08)00377-6. Retrieved from PM: 19233481. 10.1016/j.psychres.2008.10.034.
204. Liu X., Silverstein P.S., Singh V., Shah A., Qureshi N., Kumar A. Methamphetamine increases LPS-mediated expression of IL-8, TNF-α and IL-1β in human macrophages through common signaling pathways. PLoS One 2012, 7(3):e33822. 10.1371/journal.pone.0033822.
205. Liu Y., Wong T.P., Aarts M., Rooyakkers A., Liu L., Lai T.W., et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. The Journal of Neuroscience 2007, 27(11):2846-2857.
206. Lobo M.K., Covington H.E., Chaudhury D., Friedman A.K., Sun H., Damez-Werno D., et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 2010, 330(6002):385-390. Retrieved from PM: 20947769.
207. Loftis J.M., Choi D., Hoffman W., Huckans M.S. Methamphetamine causes persistent immune dysregulation: A cross-species, translational report. Neurotoxicity Research 2011, 20(1):59-68. 10.1007/s12640-010-9223-x.
208. Lu L., Dempsey J., Liu S.Y., Bossert J.M., Shaham Y. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. The Journal of Neuroscience 2004, 24(7):1604-1611.
209. Lu L., Wang X., Wu P., Xu C.M., Zhao M., Morales M., et al. Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biological Psychiatry 2009, 66(2):137-145. 10.1016/j.biopsych.2009.02.009.
210. Luo Y., Wang Y., Kuang S.Y., Chiang Y.H., Hoffer B. Decreased level of Nurr1 in heterozygous young adult mice leads to exacerbated acute and long-term toxicity after repeated methamphetamine exposure. PLoS One 2010, 5(12):e15193. Retrieved from PM: 21151937.
211. Luscher C., Malenka R.C. Drug-evoked synaptic plasticity in addiction: From molecular changes to circuit remodeling. Neuron 2011, 69(4):650-663. 10.1016/j.neuron.2011.01.017.
212. Mandyam C.D., Wee S., Eisch A.J., Richardson H.N., Koob G.F. Methamphetamine self-administration and voluntary exercise have opposing effects on medial prefrontal cortex gliogenesis. The Journal of Neuroscience 2007, 27(42):11442-11450. [pii] 27/42/11442. Retrieved from PM: 17942739. 10.1523/JNEUROSCI.2505-07.2007.
213. Maragakis N.J., Rothstein J.D. Mechanisms of disease: Astrocytes in neurodegenerative disease. Nature Clinical Practice. Neurology 2006, 2(12):679-689. [pii] ncpneuro0355. Retrieved from PM: 17117171. 10.1038/ncpneuro0355.
214. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nature Medicine 2010, 16(4):413-419. Retrieved from PM: 20348922.
215. Matsumoto R.R., Liu Y., Lerner M., Howard E.W., Brackett D.J. σ Receptors: Potential medications development target for anti-cocaine agents. European Journal of Pharmacology 2003, 469(1-3):1-12. 10.1016/s0014-2999(03)01723-0.
216. Mattson M.P., Cheng B., Baldwin S.A., Smith-Swintosky V.L., Keller J., Geddes J.W., et al. Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: Evidence for a cytoprotective response. Journal of Neuroscience Research 1995, 42:357-370.
217. Mattson M.P., Rychlik B., Cheng B. Degenerative and axon outgrowth-altering effects of phencyclidine in human fetal cerebral cortical cells. Neuropharmacology 1992, 31:279-291.
218. 1) receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neuroscience and Biobehavioral Reviews 2002, 26(4):499-527. 10.1016/s0149-7634(02)00017-9.
219. 1 receptor in the appetitive effects of cocaine. Pharmacopsychiatry 2004, 37:S198-S207. 10.1055/s-2004-832678.
220. McGinty J.F. Intra-PFC BDNF suppresses cocaine-seeking by rescuing ERK MAPK and CREB signaling. Journal of Neurochemistry 2013, 125:19.
221. McGinty J.F., Berglind W.J., Fuchs R.L., See R.E. A single BDNF infusion into the medial prefrontal cortex suppresses contextual-, cue-, and cocaine-induced reinstatement of cocaine-seeking behavior. Neuropsychopharmacology 2006, 31:S4.
222. McGinty J.F., Whitfield T.W., Berglind W.J. Brain-derived neurotrophic factor and cocaine addiction. Brain Research 2010, 1314:183-193. 10.1016/j.brainres.2009.08.078.
223. Messer C.J., Eisch A.J., Carlezon W.A., Whisler K., Shen L., Wolf D.H., et al. Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 2000, 26(1):247-257.
224. Miguel-Hidalgo J.J. The role of glial cells in drug abuse. Current Drug Abuse Reviews 2009, 2(1):76-82. Retrieved from PM: 19606280.
225. Miller G.W., Gainetdinov R.R., Levey A.I., Caron M.G. Dopamine transporters and neuronal injury. Trends in Pharmacological Sciences 1999, 20(10):424-429.
226. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nature Reviews. Neuroscience 2009, 10(1):23-36. Retrieved from PM: 19096368.
227. Minkiewicz J., de Rivero Vaccari J.P., Keane R.W. Human astrocytes express a novel NLRP2 inflammasome. Glia 2013, 61(7):1113-1121.
228. Miyaoka T., Yasukawa R., Yasuda H., Hayashida M., Inagaki T., Horiguchi J. Possible antipsychotic effects of minocycline in patients with schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007, 31(1):304-307. 10.1016/j.pnpbp.2006.08.013.
229. Miyatake M., Narita M., Shibasaki M., Nakamura A., Suzuki T. Glutamatergic neurotransmission and protein kinase C play a role in neuron-glia communication during the development of methamphetamine-induced psychological dependence. European Journal of Neuroscience 2005, 22(6):1476-1488.
230. Miyazaki Y., Adachi H., Katsuno M., Minamiyama M., Jiang Y.M., Huang Z., et al. Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nature Medicine 2012, 18(7):1136-1141. 10.1038/nm.2791.
231. Miyazaki I., Asanuma M., Diaz-Corrales F.J., Miyoshi K., Ogawa N. Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Research 2004, 1029(1):120-123. [pii] S0006-8993(04)01539-2. Retrieved from PM: 15533323. 10.1016/j.brainres.2004.09.014.
232. Miyazaki I., Asanuma M., Kikkawa Y., Takeshima M., Murakami S., Miyoshi K., et al. Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity. Glia 2011, 59(3):435-451.
233. Mizuno T., Kurotani T., Komatsu Y., Kawanokuchi J., Kato H., Mitsuma N., et al. Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 2004, 46(3):404-411. 10.1016/j.neuropharm.2003.09.009.
234. Morioka N. The roles of ATP receptors in the regulation of various functions in spinal microglia. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 2011, 131(7):1047-1052.
235. Nagatsu T. Tyrosine hydroxylase: Human isoforms, structure and regulation in physiology and pathology. Essays in Biochemistry 1995, 30:15-35.
236. Nair M.P., Mahajan S.D., Schwartz S.A., Reynolds J., Whitney R., Bernstein Z., et al. Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients. Journal of Immunology 2005, 174(11):6617-6626. Retrieved from PM: 15905500.
237. Nair M.P., Mahajan S., Sykes D., Bapardekar M.V., Reynolds J.L. Methamphetamine modulates DC-SIGN expression by mature dendritic cells. Journal of Neuroimmune Pharmacology 2006, 1(3):296-304. Retrieved from PM: 18040806. 10.1007/s11481-006-9027-1.
238. Nair M.P., Schwartz S.A., Mahajan S.D., Tsiao C., Chawda R.P., Whitney R., et al. Drug abuse and neuropathogenesis of HIV infection: Role of DC-SIGN and IDO. Journal of Neuroimmunology 2004, 157(1-2):56-60.
239. Nakagawa T., Fujio M., Ozawa T., Minami M., Satoh M. Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Behavioural Brain Research 2005, 156(2):233-239.
240. Narayanan S., Mesangeau C., Poupaert J.H., McCurdy C.R. Sigma receptors and cocaine abuse. Current Topics in Medicinal Chemistry 2011, 11(9):1128-1150. [pii] BSP/CTMC/E-Pub/-00016-11-3. Retrieved from PM: 21050176.
241. Narita M., Miyatake M., Shibasaki M., Shindo K., Nakamura A., Kuzumaki N., et al. Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse. Neuropsychopharmacology 2006, 31(11):2476-2488. 10.1038/sj.npp.1301007.
242. Navarro G., Moreno E., Aymerich M., Marcellino D., McCormick P.J., Mallol J., et al. Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(43):18676-18681. [pii] 1008911107. Retrieved from PM: 20956312. 10.1073/pnas.1008911107.
243. Nedergaard M., Ransom B., Goldman S.A. New roles for astrocytes: Redefining the functional architecture of the brain. Trends in Neurosciences 2003, 26(10):523-530. 10.1016/j.tins.2003.08.008.
244. Nikodemova M., Duncan I.D., Watters J.J. Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IκBα degradation in a stimulus-specific manner in microglia. Journal of Neurochemistry 2006, 96(2):314-323. 10.1111/j.1471-4159.2005.03520.x.
245. Nitta A., Nishioka H., Fukumitsu H., Furukawa Y., Sugiura H., Shen L., et al. Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis. Journal of Neuroscience Research 2004, 78(2):250-258. 10.1002/jnr.20258.
246. Niwa M., Nitta A., Shen L., Noda Y., Nabeshima T. Involvement of glial cell line-derived neurotrophic factor in inhibitory effects of a hydrophobic dipeptide Leu-Ile on morphine-induced sensitization and rewarding effects. Behavioural Brain Research 2007, 179(1):167-171. 10.1016/j.bbr.2007.01.026.
247. Niwa M., Nitta A., Yamada K., Nabeshima T. The roles of glial cell line-derived neurotrophic factor, tumor necrosis factor-α, and an inducer of these factors in drug dependence. Journal of Pharmacological Sciences 2007, 104(2):116-121. 10.1254/jphs.CP0070017.
248. Niwa M., Nitta A., Yamada Y., Nakajima A., Saito K., Seishima M., et al. An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization. Biological Psychiatry 2007, 61(7):890-901. 10.1016/j.biopsych.2006.06.016.
249. Noda M., Nakanishi H., Nabekura J., Akaike N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. The Journal of Neuroscience 2000, 20(1):251-258.
250. Nosrat C.A., Tomac A., Hoffer B.J., Olson L. Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs. Experimental Brain Research 1997, 115(3):410-422.
251. Ohsawa K., Irino Y., Sanagi T., Nakamura Y., Suzuki E., Inoue K., et al. P2Y12 receptor-mediated integrin-β1 activation regulates microglial process extension induced by ATP. Glia 2010, 58(7):790-801.
252. Ohta K., Kuno S., Mizuta I., Fujinami A., Matsui H., Ohta M. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sciences 2003, 73(5):617-626.
253. Ojaniemi M., Glumoff V., Harju K., Liljeroos M., Vuori K., Hallman M. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. European Journal of Immunology 2003, 33(3):597-605. 10.1002/eji.200323376.
254. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., Sesma M.A. NMDA antagonist neurotoxicity: Mechanism and prevention. Science 1991, 254(5037):1515-1518.
255. Oo T.F., Ries V., Cho J.W., Kholodilov N., Burke R.E. Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat. The Journal of Comparative Neurology 2005, 484(1):57-67. 10.1002/cne.20463.
256. Otterbein L.E., Soares M.P., Yamashita K., Bach F.H. Heme oxygenase-1: Unleashing the protective properties of heme. Trends in Immunology 2003, 24(8):449-455. [pii] S1471490603001819. Retrieved from PM: 12909459.
257. Palmer A.A., Verbitsky M., Suresh R., Kamens H.M., Reed C.L., Li N., et al. Gene expression differences in mice divergently selected for methamphetamine sensitivity. Mammalian Genome 2005, 16(5):291-305. Retrieved from PM: 16104378.
258. Paolicelli R.C., Bolasco G., Pagani F., Maggi L., Scianni M., Panzanelli P., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 2011, 333(6048):1456-1458.
259. Park I.H., Yeon S.I., Youn J.H., Choi J.E., Sasaki N., Choi I.H., et al. Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Molecular Immunology 2004, 40(16):1203-1211.
260. Parpura V., Basarsky T.A., Liu F., Jeftinija K., Jeftinija S., Haydon P.G. Glutamate-mediated astrocyte-neuron signalling. Nature 1994, 369(6483):744-747. 10.1038/369744a0.
261. Pasparakis M. Regulation of tissue homeostasis by NF-κB signalling: Implications for inflammatory diseases. Nature Reviews. Immunology 2009, 9(11):778-788. [pii] nri2655. Retrieved from PM: 19855404. 10.1038/nri2655.
262. Pawate S., Shen Q., Fan F., Bhat N.R. Redox regulation of glial inflammatory response to lipopolysaccharide and interferon-γ. Journal of Neuroscience Research 2004, 77(4):540-551. Retrieved from PM: 15264224. 10.1002/jnr.20180.
263. Pereira F.C., Cunha-Oliveira T., Viana S.D., Travassos A.S., Nunes S., Silva C., et al. Disruption of striatal glutamatergic/GABAergic homeostasis following acute methamphetamine in mice. Neurotoxicology and Teratology 2012, 34(5):522-529.
264. Pierce R.C., Bari A.A. The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Reviews in the Neurosciences 2001, 12(2):95-110.
265. Pierce R.C., Wolf M.E. Psychostimulant-induced neuroadaptations in nucleus accumbens AMPA receptor transmission. Cold Spring Harbor Perspectives in Medicine 2013, 3(2):a012021. Retrieved from PM: 23232118.
266. Pocock J.M., Kettenmann H. Neurotransmitter receptors on microglia. Trends in Neurosciences 2007, 30(10):527-535.
267. Ponath G., Schettler C., Kaestner F., Voigt B., Wentker D., Arolt V., et al. Autocrine S100B effects on astrocytes are mediated via RAGE. Journal of Neuroimmunology 2007, 184(1-2):214-222.
268. Prezzavento O., Campisi A., Ronsisvalle S., Li V.G., Marrazzo A., Bramanti V., et al. Novel sigma receptor ligands: Synthesis and biological profile. Journal of Medicinal Chemistry 2007, 50(5):951-961. Retrieved from PM: 17328523. 10.1021/jm0611197.
269. Prochiantz A., Mallat M. Astrocyte diversity. Annals of the New York Academy of Sciences 1988, 540:52-63. Retrieved from PM: 2462828.
270. Quinton M.S., Yamamoto B.K. Causes and consequences of methamphetamine and MDMA toxicity. The AAPS Journal 2006, 8(2):E337-E347. Retrieved from PM: 16796384. 10.1208/aapsj080238.
271. Ransohoff R.M., Perry V.H. Microglial physiology: Unique stimuli, specialized responses. Annual Review of Immunology 2009, 27:119-145. 10.1146/annurev.immunol.021908.132528.
272. Reichardt L.F. Neurotrophin-regulated signalling pathways. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2006, 361(1473):1545-1564. [pii] G280147415872711. Retrieved from PM: 16939974. 10.1098/rstb.2006.1894.
273. Robison A.J., Nestler E.J. Transcriptional and epigenetic mechanisms of addiction. Nature Reviews. Neuroscience 2011, 12(11):623-637.
274. Robson M.J., Noorbakhsh B., Seminerio M.J., Matsumoto R.R. Sigma-1 receptors: Potential targets for the treatment of substance abuse. Current Pharmaceutical Design 2012, 18(7):902-919.
275. Robson M.J., Turner R.C., Naser Z.J., McCurdy C.R., Huber J.D., Matsumoto R.R. SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation. Experimental Neurology 2013, 247C:134-142. 10.1016/j.expneurol.2013.04.009.
276. Rocha S.M., Cristovao A.C., Campos F.L., Fonseca C.P., Baltazar G. Astrocyte-derived GDNF is a potent inhibitor of microglial activation. Neurobiology of Disease 2012, 47(3):407-415. 10.1016/j.nbd.2012.04.014.
277. Roger T., David J., Glauser M.P., Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001, 414(6866):920-924. 10.1038/414920a.
278. Ron D., Janak P.H. GDNF and addiction. Reviews in the Neurosciences 2005, 16(4):277-285.
279. Rothman S.M., Olney J.W. Glutamate and the pathophysiology of hypoxic-Ischemic brain damage. Annals of Neurology 1986, 19:105-111.
280. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16(3):675-686. Retrieved from PM: 8785064.
281. Rubartelli A., Lotze M.T. Inside, outside, upside down: Damage-associated molecular-pattern molecules (DAMPs) and redox. Trends in Immunology 2007, 28(10):429-436.
282. Saha R.N., Liu X., Pahan K. Up-regulation of BDNF in astrocytes by TNF-α: A case for the neuroprotective role of cytokine. Journal of Neuroimmune Pharmacology 2006, 1(3):212-222. Retrieved from PM: 18040799. 10.1007/s11481-006-9020-8.
283. Saijo K., Winner B., Carson C.T., Collier J.G., Boyer L., Rosenfeld M.G., et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 2009, 137(1):47-59. Retrieved from PM: 19345186.
284. Sandhu J.K., Gardaneh M., Iwasiow R., Lanthier P., Gangaraju S., Ribecco-Lutkiewicz M., et al. Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity. Neurobiology of Disease 2009, 33(3):405-414. [pii] S0969-9961(08)00286-6. Retrieved from PM: 19118631. 10.1016/j.nbd.2008.11.016.
285. Satake K., Matsuyama Y., Kamiya M., Kawakami H., Iwata H., Adachi K., et al. Up-regulation of glial cell line-derived neurotrophic factor (GDNF) following traumatic spinal cord injury. NeuroReport 2000, 11(17):3877-3881.
286. Sattler R., Xiong Z., Lu W.Y., MacDonald J.F., Tymianski M. Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity. The Journal of Neuroscience 2000, 20(1):22-33. Retrieved from PM: 10627577.
287. Schaar D.G., Sieber B.A., Dreyfus C.F., Black I.B. Regional and cell-specific expression of GDNF in rat brain. Experimental Neurology 1993, 124(2):368-371.
288. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140(6):821-832.
289. Schubert P., Ogata T., Rudolphi K., Marchini C., McRae A., Ferroni S. Support of homeostatic glial cell signaling: A novel therapeutic approach by propentofylline. Annals of the New York Academy of Sciences 1997, 826:337-347.
290. Sekine Y., Ouchi Y., Sugihara G., Takei N., Yoshikawa E., Nakamura K., et al. Methamphetamine causes microglial activation in the brains of human abusers. The Journal of Neuroscience 2008, 28(22):5756-5761. [pii] 28/22/5756. Retrieved from PM: 18509037. 10.1523/JNEUROSCI.1179-08.2008.
291. Shah A., Silverstein P.S., Singh D.P., Kumar A. Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-κB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes. Journal of Neuroinflammation 2012, 9:52. 10.1186/1742-2094-9-52.
292. Shao Y., McCarthy K.D. Plasticity of astrocytes. Glia 1994, 11:147-155.
293. Shao Y., Porter J.T., McCarthy K.D. Neuroligand receptor heterogeneity among astroglia. Perspectives on Developmental Neurobiology 1994, 2(3):205-215. Retrieved from PM: 7850353.
294. Shao W., Zhang S.Z., Tang M., Zhang X.H., Zhou Z., Yin Y.Q., et al. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin. Nature 2013, 494(7435):90-94. [pii] nature11748. Retrieved from PM: 23242137. 10.1038/nature11748.
295. Shen F., Meredith G.E., Napier T.C. Amphetamine-induced place preference and conditioned motor sensitization requires activation of tyrosine kinase receptors in the hippocampus. The Journal of Neuroscience 2006, 26(43):11041-11051. 10.1523/JNEUROSCI.2898-06.2006.
296. Sherwood C.C., Stimpson C.D., Raghanti M.A., Wildman D.E., Uddin M., Grossman L.I., et al. Evolution of increased glia-neuron ratios in the human frontal cortex. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(37):13606-13611. 10.1073/pnas.0605843103.
297. Shoptaw S. Safety and subjective effects of ibudilast for methamphetamine dependence 2013.
298. Snider S.E., Hendrick E.S., Beardsley P.M. Glial cell modulators attenuate methamphetamine self-administration in the rat. European Journal of Pharmacology 2013, 701(1-3):124-130. 10.1016/j.ejphar.2013.01.016.
299. Snider S.E., Vunck S.A., van den Oord E., Adkins D.E., McClay J.L., Beardsley P.M. The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice. European Journal of Pharmacology 2012, 679(1-3):75-80. 10.1016/j.ejphar.2012.01.013.
300. Snyder G.L., Allen P.B., Fienberg A.A., Valle C.G., Huganir R.L., Nairn A.C., et al. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. The Journal of Neuroscience 2000, 20(12):4480-4488. Retrieved from PM: 10844017.
301. Soczynska J.K., Mansur R.B., Brietzke E., Swardfager W., Kennedy S.H., Woldeyohannes H.O., et al. Novel therapeutic targets in depression: Minocycline as a candidate treatment. Behavioural Brain Research 2012, 235(2):302-317. 10.1016/j.bbr.2012.07.026.
302. Sofroniew M.V., Vinters H.V. Astrocytes: Biology and pathology. Acta Neuropathologica 2010, 119(1):7-35.
303. Sofuoglu M., Mooney M., Kosten T., Waters A., Hashimoto K. Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. Psychopharmacology 2011, 213(1):61-68. 10.1007/s00213-010-2014-5.
304. Sofuoglu M., Sato J., Takemori A.E. Maintenance of morphine dependence by naloxone in acutely dependent mice. The Journal of Pharmacology and Experimental Therapeutics 1990, 254(3):841-846.
305. Somjen G.G. Nervenkitt: Notes on the history of the concept of neuroglia. Glia 1988, 1:2-9.
306. Sorg B.A., Chen S.Y., Kalivas P.W. Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. The Journal of Pharmacology and Experimental Therapeutics 1993, 266(1):424-430.
307. Spassky N., Merkle F.T., Flames N., Tramontin A.D., Garcia-Verdugo J.M., Alvarez-Buylla A. Adult ependymal cells are postmitotic and are derived from radial glial cells during embryogenesis. The Journal of Neuroscience 2005, 25(1):10-18. [pii] 25/1/10. Retrieved from PM: 15634762. 10.1523/JNEUROSCI.1108-04.2005.
308. Srikrishna G., Freeze H.H. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009, 11(7):615-628. Retrieved from PM: 19568407.
309. Sriram K., Miller D.B., O'Callaghan J.P. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: Role of tumor necrosis factor-α. Journal of Neurochemistry 2006, 96(3):706-718. 10.1111/j.1471-4159.2005.03566.x.
310. Stadlin A., Lau J.W., Szeto Y.K. A selective regional response of cultured astrocytes to methamphetamine. Annals of the New York Academy of Sciences 1998, 844:108-121.
311. Stella N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 2010, 58(9):1017-1030. 10.1002/glia.20983.
312. Stirling D.P., Koochesfahani K.M., Steeves J.D., Tetzlaff W. Minocycline as a neuroprotective agent. The Neuroscientist 2005, 11(4):308-322. 10.1177/1073858405275175.
313. Streit W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002, 40(2):133-139. Retrieved from PM: 12379901.
314. Strober W., Murray P.J., Kitani A., Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nature Reviews. Immunology 2006, 6(1):9-20. [pii] nri1747. Retrieved from PM: 16493424. 10.1038/nri1747.
315. Stuber G.D., Britt J.P., Bonci A. Optogenetic modulation of neural circuits that underlie reward seeking. Biological Psychiatry 2012, 71(12):1061-1067.
316. Su T.P., Hayashi T., Maurice T., Buch S., Ruoho A.E. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends in Pharmacological Sciences 2010, 31(12):557-566.
317. Sulzer D., Rayport S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechanism of action. Neuron 1990, 5(6):797-808. [pii] 0896-6273(90)90339-H. Retrieved from PM: 2268433.
318. Sulzer D., Zecca L. Intraneuronal dopamine-quinone synthesis: A review. Neurotoxicity Research 2000, 1(3):181-195. Retrieved from PM: 12835101.
319. Suzuki M., El-Hage N., Zou S., Hahn Y.K., Sorrell M.E., Sturgill J.L., et al. Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death. Molecular Neurodegeneration 2011, 6(1):78. Retrieved from PM: 22093090.
320. Suzumura A., Ito A., Yoshikawa M., Sawada M. Ibudilast suppresses TNFα production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS. Brain Research 1999, 837(1-2):203-212.
321. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276(5319):1699-1702.
322. Tang T., Rosenkranz A., Assmann K.J., Goodman M.J., Gutierrez-Ramos J.C., Carroll M.C., et al. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcγ receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. The Journal of Experimental Medicine 1997, 186(11):1853-1863. Retrieved from PM: 9382884.
323. Taylor D.L., Diemel L.T., Pocock J.M. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. The Journal of Neuroscience 2003, 23(6):2150-2160.
324. Tezuka T., Tamura M., Kondo M.A., Sakaue M., Okada K., Takemoto K., et al. Cuprizone short-term exposure: Astrocytic IL-6 activation and behavioral changes relevant to psychosis. Neurobiology of Disease 2013, 59C:63-68. Retrieved from PM: 23867234. 10.1016/j.ncbrbd.2013.07.003.
325. Theberge F.R., Li X., Kambhampati S., Pickens C.L., St. Laurent R., Bossert J.M., et al. Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving. Biological Psychiatry 2013, 73(8):729-737.
326. Theodosis D.T., Poulain D.A., Oliet S.H. Activity-dependent structural and functional plasticity of astrocyte-neuron interactions. Physiological Reviews 2008, 88(3):983-1008. Retrieved from PM: 18626065.
327. Thomas D.M., Dowgiert J., Geddes T.J., Francescutti-Verbeem D., Liu X., Kuhn D.M. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neuroscience Letters 2004, 367(3):349-354. Retrieved from PM: 15337264.
328. Thomas D.M., Francescutti-Verbeem D.M., Kuhn D.M. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. Journal of Neurochemistry 2008, 105(3):605-616. Retrieved from PM: 18088364.
329. Thomas D.M., Kuhn D.M. MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity. Brain Research 2005, 1050(1-2):190-198.
330. Thomas G.E., Szücs M., Mamone J.Y., Bem W.T., Rush M.D., Johnson F.E., et al. Sigma and opioid receptors in human brain tumors. Life Sciences 1990, 46:1279-1286.
331. Thomas D.M., Walker P.D., Benjamins J.A., Geddes T.J., Kuhn D.M. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. Journal of Pharmacology and Experimental Therapeutics 2004, 311(1):1-7.
332. Trang T., Beggs S., Wan X., Salter M.W. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. The Journal of Neuroscience 2009, 29(11):3518-3528. 10.1523/JNEUROSCI.5714-08.2009.
333. Treanor J.J., Goodman L., de Sauvage F., Stone D.M., Poulsen K.T., Beck C.D., et al. Characterization of a multicomponent receptor for GDNF. Nature 1996, 382(6586):80-83. Retrieved from PM: 8657309. 10.1038/382080a0.
334. Treweek J.B., Dickerson T.J., Janda K.D. Drugs of abuse that mediate advanced glycation end product formation: A chemical link to disease pathology. Accounts of Chemical Research 2009, 42(5):659-669. Retrieved from PM: 19275211. 10.1021/ar800247d.
335. Treweek J., Wee S., Koob G.F., Dickerson T.J., Janda K.D. Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(28):11580-11584. [pii] 0701328104. Retrieved from PM: 17592122. 10.1073/pnas.0701328104.
336. Trupp M., Arenas E., Fainzilber M., Nilsson A.S., Sieber B.A., Grigoriou M., et al. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 1996, 381(6585):785-789. Retrieved from PM: 8657281. 10.1038/381785a0.
337. Tsuda M., Inoue K., Salter M.W. Neuropathic pain and spinal microglia: A big problem from molecules in "small" glia. Trends in Neurosciences 2005, 28(2):101-107.
338. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424(6950):778-783.
339. Ullian E.M., Christopherson K.S., Barres B.A. Role for glia in synaptogenesis. Glia 2004, 47(3):209-216. 10.1002/glia.20082.
340. Van Bockstaele E.J., Colago E.E. Selective distribution of the NMDA-R1 glutamate receptor in astrocytes and presynaptic axon terminals in the nucleus locus coeruleus of the rat brain: An immunoelectron microscopic study. The Journal of Comparative Neurology 1996, 369(4):483-496. 10.1002/(SICI)1096-9861(19960610)369:4<483::AID-CNE1>3.0.CO;2-0.
341. Venero J.L., Santiago M., Tomas-Camardiel M., Matarredona E.R., Cano J., Machado A. DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury. Neuroscience 2002, 113(4):857-869.
342. Villalba M., Hott M., Martin C., Aguila B., Valdivia S., Quezada C., et al. Herpes simplex virus type 1 induces simultaneous activation of Toll-like receptors 2 and 4 and expression of the endogenous ligand serum amyloid A in astrocytes. Medical Microbiology and Immunology 2012, 201(3):371-379.
343. Virchow R. Gesammelte Abhandlungen zur Wissenschaftlichen Medicin 1856, Hamm, Frankfurt.
344. Virchow R. Cellularpathologie in ihre Begründung auf Physiogische und Pathologische Gewebelehre 1858, A. Hirschwald, Berlin, F.C. (1863), Trans.
345. Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: The revolution continues. Nature Reviews. Neuroscience 2005, 6(8):626-640.
346. Wang J.P., Bowen G.N., Zhou S., Cerny A., Zacharia A., Knipe D.M., et al. Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. Journal of Virology 2012, 86(4):2273-2281.
347. Wang X., Loram L.C., Ramos K., de Jesus A.J., Thomas J., Cheng K., et al. Morphine activates neuroinflammation in a manner parallel to endotoxin. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(16):6325-6330. 10.1073/pnas.1200130109.
348. Watkins L.R., Hutchinson M.R., Ledeboer A., Wieseler-Frank J., Milligan E.D., Maier S.F. Norman Cousins Lecture. Glia as the "bad guys": Implications for improving clinical pain control and the clinical utility of opioids. Brain, Behavior, and Immunity 2007, 21(2):131-146. 10.1016/j.bbi.2006.10.011.
349. Wilkin G.P., Marriott D.R., Cholewinski A.J. Astrocyte heterogeneity. Trends in Neurosciences 1990, 13:43-46.
350. Wilson J.X. Antioxidant defense of the brain: A role for astrocytes. Canadian Journal of Physiology and Pharmacology 1997, 75(10-11):1149-1163. Retrieved from PM: 9431439.
351. Xu Y.T., Robson M.J., Szeszel-Fedorowicz W., Patel D., Rooney R., McCurdy C.R., et al. CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain. Pharmacology, Biochemistry, and Behavior 2012, 101(1):174-180.
352. Yakovleva T., Bazov I., Watanabe H., Hauser K.F., Bakalkin G. Transcriptional control of maladaptive and protective responses in alcoholics: A role of the NF-κB system. Brain, Behavior, and Immunity 2011, 25(Suppl. 1):S29-S38. 10.1016/j.bbi.2010.12.019.
353. Yan Y., Miyamoto Y., Nitta A., Muramatsu S.-I., Ozawa K., Yamada K., et al. Intrastriatal gene delivery of GDNF persistently attenuates methamphetamine self-administration and relapse in mice. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2013, 16(7):1559-1567. 10.1017/s1461145712001575.
354. Yan Y., Nitta A., Mizuno T., Nakajima A., Yamada K., Nabeshima T. Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds. Behavioural Brain Research 2006, 173(1):39-46. 10.1016/j.bbr.2006.05.029.
355. Yan Q., Radeke M.J., Matheson C.R., Talvenheimo J., Welcher A.A., Feinstein S.C. Immunocytochemical localization of TrkB in the central nervous system of the adult rat. The Journal of Comparative Neurology 1997, 378(1):135-157.
356. Yan Y., Yamada K., Niwa M., Nagai T., Nitta A., Nabeshima T. Enduring vulnerability to reinstatement of methamphetamine-seeking behavior in glial-cell-line-derived neurotrophic factor mutant mice. FASEB Journal 2007, 21(9):1994-2004. 10.1096/fj.06-7772com.
357. Yao H., Kim K., Duan M., Hayashi T., Guo M., Morgello S., et al. Cocaine hijacks sigma1 receptor to initiate induction of activated leukocyte cell adhesion molecule: Implication for increased monocyte adhesion and migration in the CNS. The Journal of Neuroscience 2011, 31(16):5942-5955. [pii] 31/16/5942. Retrieved from PM: 21508219. 10.1523/JNEUROSCI.5618-10.2011.
358. Yenari M.A., Kauppinen T.M., Swanson R.A. Microglial activation in stroke: Therapeutic targets. Neurotherapeutics 2010, 7(4):378-391.
359. Yu Y.J., Chang C.H., Gean P.W. AMPA receptor endocytosis in the amygdala is involved in the disrupted reconsolidation of Methamphetamine-associated contextual memory. Neurobiology of Learning and Memory 2013, 103:72-81. Retrieved from PM: 23603364.
360. Zanassi P., Paolillo M., Montecucco A., Avvedimento E.V., Schinelli S. Pharmacological and molecular evidence for dopamine D(1) receptor expression by striatal astrocytes in culture. Journal of Neuroscience Research 1999, 58(4):544-552. [pii]. Retrieved from PM: 10533046. 10.1002/(SICI)1097-4547(19991115)58:4<544::AID-JNR7>3.0.CO;2-9.
361. Zhang Y., Barres B.A. Astrocyte heterogeneity: An underappreciated topic in neurobiology. Current Opinion in Neurobiology 2010, 20(5):588-594. Retrieved from PM: 20655735.
362. Zhang X., Goncalves R., Mosser D.M. The isolation and characterization of murine macrophages. Current Protocols in Immunology 2008, (Suppl. 83). Chapter 14, Unit 14.1. Retrieved from PM:19016445. 10.1002/0471142735.im1401s83.
363. Zhang L., Kitaichi K., Fujimoto Y., Nakayama H., Shimizu E., Iyo M., et al. Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006, 30(8):1381-1393. 10.1016/j.pnpbp.2006.05.015.
364. Zhang H.T., Li L.Y., Zou X.L., Song X.B., Hu Y.L., Feng Z.T., et al. Immunohistochemical distribution of NGF, BDNF, NT-3, and NT-4 in adult rhesus monkey brains. The Journal of Histochemistry & Cytochemistry 2007, 55(1):1-19. 10.1369/jhc.6A6952.2006.
365. Zhang F., Lu Y.F., Wu Q., Liu J., Shi J.S. Resveratrol promotes neurotrophic factor release from astroglia. Experimental Biology and Medicine (Maywood, N.J.) 2012, 237(8):943-948. 10.1258/ebm.2012.012044.
366. Zhou B.G., Norenberg M.D. Ammonia downregulates GLAST mRNA glutamate transporter in rat astrocyte cultures. Neuroscience Letters 1999, 276(3):145-148. [pii] S0304394099008162. Retrieved from PM:10612626.
367. Zhu X., Bergles D.E., Nishiyama A. NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development. 2008, 135(1):145-157.
368. Zhuo M., Wu G., Wu L.J. Neuronal and microglial mechanisms of neuropathic pain. Molecular Brain 2011, 4:31-34. 10.1186/1756-6606-4-31.